Wendy SOHN

Currently Global Medical Lead for Neisseria vaccines in GSK. Accountable for the global medical strategy for Bexsero, Menveo, MenABCWY 1st and 2nd Gen and N. gonorrhoeae vaccines with focus on the ACIP strategy for introduction of MenABCWY in the US, global launch readiness for MenABCWY and overall portfolio strategy. In this role, successfully led medical strategy and execution in a highly complex matrix environment, fostering collaboration across cross-functional teams while driving motivation and professional growth. Spearheaded the development of an integrated evidence generation plan, enabling new vaccine recommendations and the expansion into new age cohorts, which supported both commercial objectives and public health impact.Led the external insights which played a pivotal role in shaping clinical development plans for pipeline assets, ensuring alignment with medical and scientific priorities.Established a comprehensive scientific communication strategy, delivering impactful results through peer-reviewed publications, strategic engagements with National Immunization Technical Advisory Groups (NITAGs), and broader dissemination using innovative and omnichannel approaches. This strategy significantly enhanced the visibility and credibility of scientific evidence, influencing key decision-makers and stakeholders.Leadership in stakeholder engagement and advocacy efforts ensured effective communication of evidence, contributing to successful policy recommendations and market expansion. These achievements reflect a commitment to advancing science and public health through strategic, evidence-based approaches.

• Delivered medical leadership in highly complex cross functional environment
• Launched multiple assets in global , region and country
• lifecycle innovation in marketed and early and late stage pipeline assets
• Impactful data generation planning and execution to improve patient outcome
• Integrated scientific communication incorporating data driven publication, scientific engagements, and innovations in omnichannel approach

• 2021, Advanced Course of Vaccinology
• 2014, Future Strategy Group Asia
• 2008, INSEAD Accelerated Leadership Course
• 2007, Advanced Pharmaceutical Medicine, Seoul National University
• 2002, Pediatric Residency Samsung Medical Center, Sungkyunkwan University Hospital
• 1999, Post Graduate Internship, Shincheon Severance Hospital

• Full Name: Wendy (Woo Yun) Sohn
• Contact Information: Phone Number: +1 240 500 0635
  Email Address: wooyunsohn@gmail.com
• Location: Rockville MD US.
• Linkedin profile: www.linkedin.com/in/wendy-woo-yun-sohn-md-40801a45
• Work Authorization: Authorized to work in the US
  

• Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study., Kim KH, Kim CS, Kim HM, Kim JD, Ma SH, Kim DH, Hwang PH, Han JW, Lee TJ, Kim JH, Karkada N, Mesaros N, Sohn WY, Kim JH., Hum Immunther, 2019, 15, 2, 317-326
• Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region., Dolhain J, Janssens W, Sohn WY, Dindore V, Mukherjee P., Expert Rev Vaccines, 2019
• Cost-Utility of a Two-Dose Human Papillomavirus Vaccination Programme Added to Cervical Cancer Screening Compared with Cervical Cancer Screening Alone in Korea., Lee H, Hur S, Jang H, Lee IH, Sohn WY, Van Kriekinge G, Kim BG., Asian Pac J Cancer Prev, 2019, 02/26, 20, 2, 425-435
• Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study., Ki Hwan Kim, Chun Soo Kim, Hwang Min Kim, Jong-Duck Kim, Sang Hyuk Ma, Dong Ho Kim, Pyoung-Han Hwang, JiWhan Han, Taek-Jin Lee, Joon Hyung Kim, Naveen Karkada, Narcisa Mesaros, Woo-Yun Sohn, Jong-Hyun Kim., Hum Vaccin Immunother, 2019, 15, 2, 317-326
• Cost-effectiveness analysis of AS04-adjuvanted Human Papillomavirus 16/18 Vaccine compared with Human papillomavirus 6/11/16/18 vaccine in Singapore, with two dose schedule., Tay SK, Lee BW, Sohn WY, Lee IH, Mathur G, Sanicas M, Van Kriekinge G., Asia-Oceania Research Organisation in Genital Infection and Neoplasia, Singapore, 08/12-14/16
• CEA of AS04 adjuvanted HPV 16/18 vaccine compared with HPV 6/11/18/19 vaccine in adolescent girls in Malaysia, with new 2 dose schedule., Van Kriekinge et al., 24th AOCOG, Sarawak, Malaysia, 2015
• Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in adolescent girls in Korea, with the new 2-dose schedule., Hyunju Lee, Byoung-Gie Kim, Sooyoung Hur, Hyeongap Jang, I-Heng Lee, Woo-Yun Sohn, Georges Van Kriekinge., 9th Vaccine & ISV Congress, Seoul, Korea, 2015
• Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with screening alone in adolescent girls in Korea, with the new 2-dose schedule., Sooyoung Hur, Hyunju Lee, Hyeongap Jang, I-Heng Lee, Woo-Yun Sohn, Georges Van Kriekinge, Byoung-Gie Kim., 4th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO), Seoul, Korea, 2015
• Economic burden of otitis media and a survey of physicians for its practice and claim codes in Korea., Chun BC, Sohn WY, Jung WJ, Lee HJ., J Korean Med Assoc, 2013, 56, 1, 62-71
• Genetic diversity of the ftsI gene in β-lactamase-nonproducing ampicillin-resistant and β-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in South Korea., Park C, Kim KH, Shin NY, Byun JH, Kwon EY, Lee JW, Kwon HJ, Choi EY, Lee DG, Sohn WY, Kang JH., Microb Drug Resist, 2013, 06, 19, 3, 224-30, 10.1089/mdr.2012.0116
• Reason for investigators to participate in industry sponsored clinical trials., Joon Hyun Kim et al., Korean Pharmaceutical Medicine, 2011, 19, 1, 14-22
• Clinical assessment of primary immunodeficiency in one hospital in Seoul from 1996 to 2004., Lee JH, Sohn WY et al., J Korean Paediatric Allergy and Respiratory, 2005, 4, 368-80
• Relationship between chronologic age and bone age at diagnosis of central precocious puberty., J Korean Pediatric Endocrinology, 2005, 10, 1, 90-94
• Clinical and laboratory features of Korean Mucopolysaccharidosis and mucolipidosis., Sohn WY et al., Korean J Pediatrics, 2005, 48, 10, 1132-1138
• Chemoreduction followed by local therapy and adjuvant chemotherapy for advanced intraocular retinoblastoma: a pilot study in a single center., Yoo KH, Sohn WY, Sung KW, Jung HL, Koo HH, Oh SY, Kang SW., J Kor Med Sci, 2002, 12, 17, 6, 817-22
• Beyond B antigen coverage. The potential of the 4CMenB Vaccine for cross-protection against pathogenic Neisseria infections., Y Garcia, WY Sohn, Mariagrazia Pizza, Rafik Bekkat-Berkani., Open Forum Infect Dis, 2021
• Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect., Y Garcia, WY Sohn, K Seib, MK Taha JA Vazquez, Ana Paula S de Lemos, K Vadivelu, MG Pizza R Rappuoli, R Bekkat Bekani., NPJ Vaccines, 2021, 6, 130
• Pandemic's influence on parents attitudes and behaviors toward meningococcal vaccination., LJ Tan, MA P. Safadi, M Horn, CR Balboa, EM Moya, J Schanbaum, P Pimenta, E Lambert, L Soumahoro, WY Sohn, T Bruce, YR García., Hum Vaccin Immunother, 2023, 19, 1, 217840
• Real world implementation of 4CMenB: implications for clinical practice., WY Sohn, H Tahrat, P Novy, R Bekkat-Berkani., Expert Rev Vaccines, 2022, 21, 3, 325-35
• Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CEMnB., R Bekkat-Berkani, E Fragapane, S Preiss, R Rappuoli, WY Sohn, L Soumahoro, K Vadivelu., JID, 2022, 85, 5, 481-91
• Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context., Y Garcia, J Marrazzo F. Martinon-Torres, K Workowski, G Giordano, Pizza, WY Sohn., J Infect Dis, 2024, 16, 230, e758-67
• Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases., Eddie Gibson, Daniel A. Ollendorf, Steven Simoens, David E Bloom, Federico Martinón-Torres, David Salisbury, Johan Louis Severens, Mondher Toumi, Daniel Molnar, Kinga Meszaros, Woo-Yun Sohn, Najida Begum., J Mark Access Health Policy, 2023, 11, 1, 2239557
• The Diverse Spectrum of Invasive Meningococcal Disease in Pediatric and Adolescent Patients: Narrative Review of Cases and Case Series., Shravani Bobde, Woo-Yun Sohn, Rafik Bekkat-Berkani, Angelika Banzhoff, Athena Cavounidis, Ener Cagri Dinleyici, Wilfrido Coronell Rodriguez, Nelly Ninis., Infect Dis Ther, 2024, 02, 13, 2, 251-271
• Meningococcal B Immunization for Adolescents in the Presence of Added Gonorrhea Protection: A Public Health Impact Modelling Study in the United States., Zeki Kocaata, Menaka Bhor, Woo-Yun Sohn, Kinga Meszaros., Open Forum Infect Dis, 2023, 12, 10, Suppl 2

• MD
• Pediatric specialist